Free Trial

Randall K. Fields Sells 7,500 Shares of ReposiTrak (NYSE:TRAK) Stock

ReposiTrak logo with Computer and Technology background

Key Points

  • CEO Randall Fields of ReposiTrak sold 7,500 shares at an average price of $16.06, reducing his ownership by 8.62%.
  • The company recently cut its quarterly dividend to $0.0182 per share, reflecting an annualized yield of 0.4%.
  • ReposiTrak received an upgrade from a "hold" to a "buy" rating by analysts at Wall Street Zen.
  • MarketBeat previews the top five stocks to own by November 1st.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 7,500 shares of ReposiTrak stock in a transaction on Monday, September 8th. The stock was sold at an average price of $16.06, for a total transaction of $120,450.00. Following the completion of the transaction, the chief executive officer directly owned 79,500 shares in the company, valued at $1,276,770. This represents a 8.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

ReposiTrak Stock Down 1.3%

Shares of TRAK traded down $0.22 during trading hours on Friday, reaching $16.98. 33,886 shares of the company traded hands, compared to its average volume of 49,281. The company has a market capitalization of $310.39 million, a PE ratio of 49.94 and a beta of 0.47. The company has a quick ratio of 6.03, a current ratio of 6.03 and a debt-to-equity ratio of 0.01. ReposiTrak Inc. has a 12-month low of $15.12 and a 12-month high of $25.01. The stock has a fifty day simple moving average of $17.27.

ReposiTrak Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 14th. Stockholders of record on Monday, June 30th were issued a dividend of $0.0182 per share. The ex-dividend date of this dividend was Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.4%. ReposiTrak's payout ratio is 20.59%.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

Get Our Latest Report on ReposiTrak

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets lifted its position in ReposiTrak by 63.5% during the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock valued at $32,000 after purchasing an additional 634 shares during the period. Ingalls & Snyder LLC lifted its position in ReposiTrak by 1.3% during the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock valued at $3,905,000 after purchasing an additional 2,554 shares during the period. Tower Research Capital LLC TRC lifted its position in ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock valued at $71,000 after purchasing an additional 2,892 shares during the period. Ellsworth Advisors LLC lifted its position in ReposiTrak by 10.6% during the first quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company's stock valued at $634,000 after purchasing an additional 2,997 shares during the period. Finally, American Century Companies Inc. lifted its position in ReposiTrak by 17.4% during the second quarter. American Century Companies Inc. now owns 23,344 shares of the company's stock valued at $459,000 after purchasing an additional 3,455 shares during the period. 27.35% of the stock is currently owned by institutional investors and hedge funds.

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Read More

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.